Corpus Intelligence IC Memo — PHELPS MEMORIAL HEALTH CENTER 2026-04-26 05:06 UTC
IC Memo — PHELPS MEMORIAL HEALTH CENTER
Investment Committee Memorandum | NE | 25 beds | Grade C | EBITDA uplift $5.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

PHELPS MEMORIAL HEALTH CENTER

CCN 281362 | PHELPS, NE | 25 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

PHELPS MEMORIAL HEALTH CENTER is a 25-bed rural/critical access in PHELPS, NE with $69.0M in net patient revenue and a 8.2% operating margin. The hospital serves a payer mix of 67.5% Medicare, 5.8% Medicaid, and 26.7% commercial.

Thesis: Turnaround. Our ML models identify $5.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 8.2% to 15.6% (+736bps).

Net Revenue HCRIS$69.0M
Current EBITDA COMPUTED$5.7M
Operating Margin COMPUTED8.2%
Occupancy HCRIS32.4%
Revenue / Bed COMPUTED$2.8M
Net-to-Gross HCRIS58.7%
Distress Probability ML55.0%

2. Market Context & Competitive Position

98
NE Hospitals
-6.3%
State Median Margin
65
Comparable Hospitals

NE has 98 Medicare-certified hospitals with a median operating margin of -6.3%. The target's margin of 8.2% places it above the state median. Among 65 size-comparable peers (12-50 beds), the median margin is -4.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 65 hospitals in the comp set.

HospitalStateBedsRevenueMargin
PHELPS MEMORIAL HEALTH CENTER (Target)NE25$69.0M8.2%
COLUMBUS COMMUNITY HOSPITALNE50$137.1M-1.2%
FREMONT HEALTHNE50$130.0M7.1%
NEBRASKA ORTHOPAEDIC HOSPITAL NE24$112.1M22.5%
BEATRICE COMMUNITY HOSPITALNE25$84.6M-1.2%
LINCOLN SURGICAL HOSPITALNE20$80.9M18.8%
MIDWEST SURGICAL HOSPITALNE19$70.1M36.2%
SIDNEY REGIONAL MEDICAL CENTERNE19$68.0M0.8%
COMMUNITY HOSPITAL ASSOCOCIATINE25$56.0M-7.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $5.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.4M+210bp18mo
Cost to Collect4.5%2.5%$1.4M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.4M+198bp12mo
A/R Days Reduction5200.0%3800.0%$839K+122bp9mo
Clean Claim Rate88.0%96.0%$44K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.4M
Cost to Collect
$1.4M
Denial Rate Reduction
$1.4M
A/R Days Reduction
$839K
Clean Claim Rate
$44K
Total EBITDA Uplift$5.1M
Current EBITDA$5.7M
+ RCM Uplift+$5.1M
Pro Forma EBITDA$10.7M
Current Margin8.2%
Pro Forma Margin15.6%
WC Released (1x)$2.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$8.7M$88.1M10.12x58.9%
Base (11x exit)10.0x11.0x$8.7M$99.8M11.45x62.8%
Bull Case9.0x11.0x$7.8M$119.3M15.22x72.4%
Bull (12x exit)9.0x12.0x$7.8M$132.5M16.90x76.0%
Bear Case11.0x10.0x$9.6M$59.9M6.25x44.3%
Bear (11x exit)11.0x11.0x$9.6M$69.0M7.20x48.4%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 67.5% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
MediumLow occupancyAt 32.4%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 55.0% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 65 hospitals with 12-50 beds
  • Same-state prioritization (n=66)
  • Comp margins: P25=-13.0% / P50=-4.8% / P75=0.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.